• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Eli Lil­ly joins the grow­ing ranks of Big Phar­ma play­ers man­dat­ing vac­ci­na­tions for most staffers

4 years ago
Pharma

No­vavax, Fu­ji­film plow ahead on Covid-19 vac­cine pro­duc­tion de­spite OWS set­back

4 years ago
Coronavirus
Manufacturing

In its quest to bring ALS drug to mar­ket, Clene will ex­pand man­u­fac­tur­ing in Mary­land

4 years ago
Manufacturing

Man­u­fac­tur­ing is­sues hold back dis­tri­b­u­tion of over­dose in­jec­tion; San Diego biotech triples foot­print

4 years ago
Manufacturing

FDA says it needs a lit­tle more time to de­cide on Mer­ck­'s P2X3 for chron­ic cough

4 years ago
FDA+

Pe­ter Thiel-backed ATAI launch­es new Salvia-fo­cused biotech; Pur­due bank­rupt­cy tri­al ex­pect­ed to be­gin to­day — ...

4 years ago
News Briefing

Two da­ta fal­si­fiers sen­tenced to prison as FDA pledges to crack down on those un­der­min­ing clin­i­cal tri­als

4 years ago
FDA+

Aprea dis­clos­es sec­ond clin­i­cal hold in a week, this time for lym­phoma study

4 years ago
FDA+

First gener­ic com­pe­ti­tion ar­rives for Pfiz­er's megablock­buster an­ti-smok­ing drug

4 years ago
Pharma
FDA+

Mer­ck nabs ap­proval for Keytru­da com­bo in kid­ney can­cer af­ter prov­ing it can ex­tend sur­vival

4 years ago
R&D
FDA+

Biden's vi­sion for drug pric­ing re­forms: Medicare ne­go­ti­a­tions, penal­ties for prices ris­ing high­er than in­fla­tion

4 years ago
Pharma

A uni­corn bags an­oth­er $220M to fund its plans to up­end the clin­i­cal tri­al process

4 years ago
Financing

Sen. Rand Paul re­veals his wife bought Gilead stock in Feb­ru­ary 2020 — 16 months af­ter fil­ing dead­line

4 years ago
People
Pharma

Mer­ck part­ner Arti­va blue­prints San Diego R&D, man­u­fac­tur­ing site to take NK cell op­er­a­tion to the next lev­el

4 years ago
Cell/Gene Tx
Manufacturing

Out to re­vamp plant-based drug man­u­fac­tur­ing, An­theia locks in part­ner­ship with syn­thet­ic bi­ol­o­gy gi­ant Gink­go

4 years ago
Deals
Manufacturing

Covid-19 roundup: OCD drug shows 31% hos­pi­tal­iza­tion re­duc­tion in plat­form tri­al; EUA for boost­er mR­NA shot im­mi­nent ...

4 years ago
Coronavirus

Pur­due sub­sidiary nabs non-opi­oid drug for pain; Or­biMed backs small biotech's 'su­pe­ri­or' drug

4 years ago
News Briefing

Lead­ing an­ti-ag­ing re­searcher Aubrey de Grey ac­cused of sex­u­al ha­rass­ment by two col­leagues, in­clud­ing while one was ...

4 years ago
People

Heat Bi­o­log­ics goes back to San An­to­nio to build a re­search and man­u­fac­tur­ing fa­cil­i­ty

4 years ago
R&D
Manufacturing

Scoop: VA de­cides against adding Bio­gen's Aduhelm to its for­mu­la­ry as PBM shuns con­tro­ver­sial Alzheimer's drug

4 years ago
Pharma

The Car­lyle Group ax­es auc­tion by call­ing its $1.3B bid for Vec­tura 'fi­nal' — now the ball is in Philip Mor­ris' ...

4 years ago
Deals

As Ab­b­Vie and Soli­ton shake hands on a $550M merg­er, the FTC says 'not so fast'

4 years ago
Deals

FDA re­jects Fi­bro­Gen's ane­mia drug, de­mand­ing an ad­di­tion­al clin­i­cal tri­al

4 years ago
Pharma
FDA+

'The con­sum­mate men­tor': Bill Clin­ton, Jim Wil­son and oth­ers re­flect on Tachi Ya­mada's life and lega­cy

4 years ago
People
In Focus
First page Previous page 652653654655656657658 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times